These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 18007150)

  • 1. Prediction of antiangiogenic treatment efficacy by iron oxide enhanced parametric magnetic resonance imaging.
    Persigehl T; Matuszewski L; Kessler T; Wall A; Meier N; Ebert W; Berdel WE; Heindel W; Mesters R; Bremer C
    Invest Radiol; 2007 Dec; 42(12):791-6. PubMed ID: 18007150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice.
    Persigehl T; Bieker R; Matuszewski L; Wall A; Kessler T; Kooijman H; Meier N; Ebert W; Berdel WE; Heindel W; Mesters RM; Bremer C
    Radiology; 2007 Aug; 244(2):449-56. PubMed ID: 17562810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of bevacizumab-induced antiangiogenic treatment effects by "steady state" ultrasmall superparamagnetic iron oxide particles magnetic resonance imaging using robust multiecho ΔR2* relaxometry.
    Ring J; Persigehl T; Remmele S; Heindel W; Dahnke H; Bremer C
    Invest Radiol; 2011 May; 46(5):326-30. PubMed ID: 21358548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor blood volume determination by using susceptibility-corrected DeltaR2* multiecho MR.
    Persigehl T; Wall A; Kellert J; Ring J; Remmele S; Heindel W; Dahnke H; Bremer C
    Radiology; 2010 Jun; 255(3):781-9. PubMed ID: 20501715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of bone marrow angiogenesis in patients with acute myeloid leukemia by using contrast-enhanced MR imaging with clinically approved iron oxides: initial experience.
    Matuszewski L; Persigehl T; Wall A; Meier N; Bieker R; Kooijman H; Tombach B; Mesters R; Berdel WE; Heindel W; Bremer C
    Radiology; 2007 Jan; 242(1):217-24. PubMed ID: 17116730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging monitors physiological changes with antihedgehog therapy in pancreatic adenocarcinoma xenograft model.
    Guimaraes AR; Rakhlin E; Weissleder R; Thayer SP
    Pancreas; 2008 Nov; 37(4):440-4. PubMed ID: 18953259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of VEGF receptor kinase inhibitor-induced antiangiogenic effects in drug-resistant human adenocarcinoma model.
    Reichardt W; Hu-Lowe D; Torres D; Weissleder R; Bogdanov A
    Neoplasia; 2005 Sep; 7(9):847-53. PubMed ID: 16229807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric characterization of response to anti-angiogenic therapy using USPIO contrast-enhanced MRI in combination with dynamic contrast-enhanced MRI.
    Kim J; Kim E; Euceda LR; Meyer DE; Langseth K; Bathen TF; Moestue SA; Huuse EM
    J Magn Reson Imaging; 2018 Jun; 47(6):1589-1600. PubMed ID: 29205621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. αvß3-Integrin-Targeted Magnetic Resonance Imaging for the Assessment of Early Antiangiogenic Therapy Effects in Orthotopic Breast Cancer Xenografts.
    Kazmierczak PM; Schneider M; Habereder T; Hirner-Eppeneder H; Eschbach RS; Moser M; Reiser MF; Lauber K; Nikolaou K; Cyran CC
    Invest Radiol; 2016 Nov; 51(11):746-755. PubMed ID: 27082316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles.
    Cui Y; Zhang C; Luo R; Liu H; Zhang Z; Xu T; Zhang Y; Wang D
    Int J Nanomedicine; 2016; 11():5671-5682. PubMed ID: 27895477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
    Marzola P; Degrassi A; Calderan L; Farace P; Nicolato E; Crescimanno C; Sandri M; Giusti A; Pesenti E; Terron A; Sbarbati A; Osculati F
    Clin Cancer Res; 2005 Aug; 11(16):5827-32. PubMed ID: 16115922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the early effects of 5,6-dimethylxanthenone-4-acetic acid using macromolecular contrast media-enhanced magnetic resonance imaging: ectopic versus orthotopic tumors.
    Seshadri M; Bellnier DA; Cheney RT
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1198-207. PubMed ID: 18954713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic gadobutrol-enhanced MRI predicts early response to antivascular but not to antiproliferation therapy in a mouse xenograft model.
    Dassler K; Scholle FD; Schütz G
    Magn Reson Med; 2014 May; 71(5):1826-33. PubMed ID: 23754607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
    Szentirmai O; Baker CH; Lin N; Szucs S; Takahashi M; Kiryu S; Kung AL; Mulligan RC; Carter BS
    Neurosurgery; 2006 Feb; 58(2):365-72; discussion 365-72. PubMed ID: 16462491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculature.
    Kessler T; Bieker R; Padró T; Schwöppe C; Persigehl T; Bremer C; Kreuter M; Berdel WE; Mesters RM
    Clin Cancer Res; 2005 Sep; 11(17):6317-24. PubMed ID: 16144936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126.
    Evelhoch JL; LoRusso PM; He Z; DelProposto Z; Polin L; Corbett TH; Langmuir P; Wheeler C; Stone A; Leadbetter J; Ryan AJ; Blakey DC; Waterton JC
    Clin Cancer Res; 2004 Jun; 10(11):3650-7. PubMed ID: 15173071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice.
    de Lussanet QG; Backes WH; Griffioen AW; van Engelshoven JM; Beets-Tan RG
    Radiology; 2003 Nov; 229(2):429-38. PubMed ID: 14595147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arginine-glycine-aspartic polypeptide mediated truncated tissue factor therapy for colorectal carcinoma].
    Huang ZJ; Luo Q; Yan JH; Wang SY
    Zhonghua Wai Ke Za Zhi; 2010 Apr; 48(8):619-24. PubMed ID: 20646482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of superparamagnetic iron oxide nanoparticles in the liver of body-temperature-controlled mice using dynamic susceptibility contrast magnetic resonance imaging and an empirical mathematical model.
    Murase K; Assanai P; Takata H; Matsumoto N; Saito S; Nishiura M
    Magn Reson Imaging; 2015 Jun; 33(5):600-10. PubMed ID: 25683514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualization of rodent brain tumor angiogenesis and effects of antiangiogenic treatment using 3D ΔR2-μMRA.
    Lin CY; Siow TY; Lin MH; Hsu YH; Tung YY; Jang T; Recht L; Chang C
    Angiogenesis; 2013 Oct; 16(4):785-93. PubMed ID: 23736837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.